Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18720931 | 0.92 | TRPA1 (0.42) | TRPA1TRPM8EPHX1 | |
| SCHEMBL16191447 | 0.90 | TRPA1 (0.37) | TRPA1TRPM8 | |
| SCHEMBL1270214 | 0.84 | TRPA1 (0.46) | TRPA1TRPM8ALDH1A1EPHX1 | |
| SCHEMBL4661801 | 0.83 | TRPA1 (0.33) | TRPA1TRPM8 | |
| SCHEMBL280337 | 0.81 | TRPA1 (0.52) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL22026406 | 0.81 | TRPA1 (0.36) | TRPA1TRPM8 | |
| SCHEMBL680648 | 0.81 | TRPA1 (0.52) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL7752845 | 0.81 | TRPA1 (0.52) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL22601293 | 0.81 | TRPA1 (0.52) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL16202652 | 0.81 | TRPA1 (0.52) | TRPA1TRPM8CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230255105-A1 | ORGANIC COMPOUNDS WITH DELAYED FLUORESCENCE EMISSION AND CIRCULARLY POLARISED LUMINESCENCE AND USE THEREOF | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2023-08-10 | — | — | US | disclosed |
| CN-111073914-A | Process for preparing trans-1, 2-cyclohexanedimethanol | 江苏威凯尔医药科技有限公司 | 2020-04-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255105-A1 | ORGANIC COMPOUNDS WITH DELAYED FLUORESCENCE EMISSION AND CIRCULARLY POLARISED LUMINESCENCE AND USE THEREOF | TEAD2, TEAD4, AAAS | TRPA1 173/4885TRPM8 922/4885CA1 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.